RGNX
Regenxbio Inc
7.40$
+2.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.8% | 53.4% | 54.1% | 84.6% | 62.1% | 69.3% | 75.0% | 46.6% | 49.9% | 58.4% | 59.7% | 62.1% | |
| 32.1% | 24.4% | 14.4% | 23.5% | 13.9% | 14.0% | 47.8% | 31.0% | 11.6% | 6.0% | 12.3% | 7.6% | |
| 32.1% | 51.6% | 51.8% | 80.9% | 58.8% | 59.5% | 67.2% | 41.1% | 43.8% | 48.0% | 50.4% | 50.8% | |
| 53.9% | 1.0% | 0.6% | 0.2% | 1.6% | 7.7% | 6.1% | 2.9% | 3.6% | 4.6% | 4.6% | 6.0% | |
| 0.0% | 0.5% | 1.0% | 2.7% | 1.1% | 1.3% | 1.5% | 1.7% | 1.7% | – | – | – | |
| 15.4% | 0.2% | 5.4% | 7.0% | 5.3% | 7.8% | 8.0% | 17.3% | 24.8% | – | – | – | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 263.2% | 2.1% | 6.4% | 7.9% | 6.4% | 9.6% | 46.7% | 31.4% | 38.1% | 45.7% | 44.3% | 77.3% | |
| 263.2% | 2.0% | 5.6% | 7.3% | 4.1% | 6.8% | 11.5% | 11.7% | 15.7% | 22.7% | 22.1% | 26.1% | |
| 109.6% | – | – | – | – | 0.5% | 0.4% | 0.2% | 0.7% | 1.2% | 1.7% | 10.6% | |
| 9.6% | 0.5% | 0.9% | 2.4% | 0.8% | 1.3% | 1.5% | 1.0% | 3.3% | 4.0% | 4.9% | 4.7% | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| -163.2% | 97.9% | 93.6% | 92.1% | 93.6% | 90.4% | 53.3% | 68.6% | 61.9% | 54.3% | 55.7% | 22.7% | |
| -825.2% | -23.3% | -66.3% | -94.5% | -15.3% | -35.7% | -40.8% | -14.5% | -53.0% | -122.8% | -200.0% | -248.6% | |
| 376.7% | 4.1% | 15.3% | 15.0% | 6.7% | 7.4% | 5.3% | 3.9% | 5.2% | 7.6% | 10.6% | 11.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.